Other Current Liabilities
Abbott Other Current Liabilities increased by 13.1% to $3.87B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.1%, from $3.42B to $3.87B. Over 4 years (FY 2021 to FY 2025), Other Current Liabilities shows relatively stable performance with a 0.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A spike in this area might indicate rising operational costs or a buildup of deferred revenue from subscription-based services.
Detailed definition
Short-term obligations that are expected to be settled within one year but are not classified as accounts payable or sho...
Peer comparison
For software-heavy companies, this often includes significant deferred revenue, which is a positive indicator of future earnings.
other_current_liabilitiesHistorical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $3.74B | $4.12B | $3.68B | $3.42B | $3.87B |
| QoQ Change | — | +10.3% | -10.7% | -7.0% | +13.1% |
| YoY Change | — | +10.3% | -10.7% | -7.0% | +13.1% |
Other Current Liabilities at Other Companies
Frequently Asked Questions
- What is Abbott's other current liabilities?
- Abbott (ABT) reported other current liabilities of $3.87B in Q4 2025.
- How has Abbott's other current liabilities changed year-over-year?
- Abbott's other current liabilities increased by 13.1% year-over-year, from $3.42B to $3.87B.
- What is the long-term trend for Abbott's other current liabilities?
- Over 4 years (2021 to 2025), Abbott's other current liabilities has grown at a 0.9% compound annual growth rate (CAGR), from $3.74B to $3.87B.
- What does other current liabilities mean?
- Miscellaneous short-term debts and obligations that must be paid within the next year.